Literature DB >> 5766189

Philippine hemorrhagic fever: a clinical, laboratory, and necropsy study.

J W Fresh, V Reyes, E J Clarke, C V Uylangco.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1969        PMID： 5766189

Source DB:  PubMed          Journal:  J Lab Clin Med        ISSN： 0022-2143


× No keyword cloud information.
  7 in total

1.  A lethal murine infection model for dengue virus 3 in AG129 mice deficient in type I and II interferon receptors leads to systemic disease.

Authors:  Vanessa V Sarathy; Mellodee White; Li Li; Summer R Gorder; Richard B Pyles; Gerald A Campbell; Gregg N Milligan; Nigel Bourne; Alan D T Barrett
Journal:  J Virol       Date:  2014-11-12       Impact factor: 5.103

Review 2.  Endothelial cells in dengue hemorrhagic fever.

Authors:  Anon Srikiatkhachorn; James F Kelley
Journal:  Antiviral Res       Date:  2014-07-12       Impact factor: 5.970

3.  Case Management of Dengue: Lessons Learned.

Authors:  Siripen Kalayanarooj; Alan L Rothman; Anon Srikiatkhachorn
Journal:  J Infect Dis       Date:  2017-03-01       Impact factor: 5.226

4.  Dengue virus-elicited tryptase induces endothelial permeability and shock.

Authors:  Abhay Ps Rathore; Chinmay Kumar Mantri; Siti Ab Aman; Ayesa Syenina; Justin Ooi; Cyril J Jagaraj; Chi Ching Goh; Hasitha Tissera; Annelies Wilder-Smith; Lai Guan Ng; Duane J Gubler; Ashley L St John
Journal:  J Clin Invest       Date:  2019-07-02       Impact factor: 14.808

5.  Pathogenetic mechanisms in dengue haemorrhagic fever: report of an international collaborative study.

Authors: 
Journal:  Bull World Health Organ       Date:  1973       Impact factor: 9.408

6.  Observations related to pathogensis of dengue hemorrhagic fever. VI. Hypotheses and discussion.

Authors:  S B Halstead
Journal:  Yale J Biol Med       Date:  1970-04

Review 7.  Vascular events in viral hemorrhagic fevers: a comparative study of dengue and hantaviruses.

Authors:  Anon Srikiatkhachorn; Christina F Spiropoulou
Journal:  Cell Tissue Res       Date:  2014-03-13       Impact factor: 5.249
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.